PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Purified extract of A. fruticosa (100 mg/kg) in diabetic spontaneously hypertensive rats caused significant decreases in blood glucose levels, systolic pressure, and MDA quantity [PMID:40733441, 35735617]. Amorfrutins demonstrated antidiabetic effects in diet-induced obese and db/db mice [PMID:22509006].
Prenylated phenols from fruits reduced survival of human cervical (HeLa) and colon (HT-29, HCT-116, LS174) tumor cells [PMID:38733625]. Rotenoid glycosides from seeds showed selective cytotoxicity against MCF-7 and HCT-116 cell lines [PMID:25449424]. Leaf extracts showed inhibitory effects on HCT116 cells [PMID:28987377].
Essential oil from fresh fruit reduced the number of writhes in acetic acid-induced rats, with a 400 mg/kg dose demonstrating 54.4% inhibition [PMID:39519963].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36177113 (2022) — A review on invasive false indigo bush (Amorpha fruticosa L.): Nuisance plant with multiple benefits. · Ecology and evolution
- 2.PMID: 38733625 (2025) — Cytotoxic prenylated phenols of false indigo-bush (Amorpha fruticosa L.). · Natural product research
- 3.PMID: 28642702 (2017) — Amorpha fruticosa - A Noxious Invasive Alien Plant in Europe or a Medicinal Plant against Metabolic Disease? · Frontiers in pharmacology
- 4.PMID: 39519963 (2024) — Chemodiversity and Antinociceptive Activity of Amorpha fruticosa L. Essential Oil. · Plants (Basel, Switzerland)
- 5.PMID: 35877420 (2022) — Amorphigenin from Amorpha fruticosa L. Root Extract Induces Autophagy-Mediated Melanosome Degradation in mTOR-Independent- and AMPK-Dependent Manner.